Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mepolizumab

EU orphan designation number: EU/3/13/1116   
Active ingredient: Mepolizumab
Indication: Treatment of Churg-Strauss Syndrome
Sponsor: Glaxo Group Ltd
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/174/12 (2013)1610 of 12/03/2013
04/02/2014 Centralised Orphan - Change of address